MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM Trademark

Trademark Overview


On Monday, August 12, 2024, a trademark application was filed for MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM trademark a serial number of 98693972. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 10, 2025. This trademark is owned by The Multiple Myeloma Research Foundation, Inc.. The MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information about the treatment of multiple myeloma via a global computer network.

Medical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaboration, accelerated research efforts, and the advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global computer network.
mm rc multiple myeloma research consortium

General Information


Serial Number98693972
Word MarkMM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM
Filing DateMonday, August 12, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of two letters "M" above the letters "R" and "C" with a border surrounding the letters and is broken at the top let and bottom right corners with the words MULTIPLE MYELOMA RESEARCH CONSORTIUM to the right of the border.
Pseudo MarkMULTIPLE MYELOMA RESEARCH CONSORTIUM MULTIPLE MYELOMA RESEARCH CONSORTIUM
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding medical information about the treatment of multiple myeloma via a global computer network.
Goods and ServicesMedical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaboration, accelerated research efforts, and the advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global computer network.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 12, 2024
Primary Code042
First Use Anywhere DateWednesday, April 30, 2014
First Use In Commerce DateWednesday, April 30, 2014

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 12, 2024
Primary Code044
First Use Anywhere DateWednesday, April 30, 2014
First Use In Commerce DateWednesday, April 30, 2014

Trademark Owner History


Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNorwalk, CT 06851

Trademark Events


Event DateEvent Description
Monday, August 12, 2024NEW APPLICATION ENTERED
Tuesday, February 25, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 26, 2025ASSIGNED TO EXAMINER
Friday, February 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 28, 2025NON-FINAL ACTION E-MAILED
Friday, February 28, 2025NON-FINAL ACTION WRITTEN
Monday, March 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 10, 2025NON-FINAL ACTION WRITTEN
Thursday, April 10, 2025NON-FINAL ACTION E-MAILED
Thursday, April 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED